Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Finasteride may reduce bleeding after TURP, but more research needed.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

A woman with lupus had rare severe symptoms but improved with treatment.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Hair-thread Tourniquet Syndrome, where hair or thread tightly wraps around a body part, is not rare and requires early detection to prevent serious damage.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Erectile dysfunction in young men is caused by both mental and physical factors and needs a personalized treatment approach.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Serenoa repens extract shows promise as a natural treatment for prostate cancer.

Autonomous robotic surgery is advancing but still requires human supervision for complex procedures.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

New treatments for male hypogonadism are effective and should be personalized.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Finasteride reduces prostate size and PSA levels in young patients.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.